HomeAstraZeneca share price slides despite positive trial resultsAstraZeneca share price slides despite positive trial results

AstraZeneca share price slides despite positive trial results

Most Read

AIM movers: Merit profit recovery and ex-dividends

25/04/2024

Barclays shares jump as income and profits beat expectations

25/04/2024

Sainsbury’s strategy to focus on food leads to sales growth

25/04/2024

Anglo American shares surge higher as BHP proposes takeover

25/04/2024